Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2023 May;25(5):100804
Date
03/28/2023Pubmed ID
36971772DOI
10.1016/j.gim.2023.100804Scopus ID
2-s2.0-85152941721 (requires institutional sign-in at Scopus site) 6 CitationsAuthor List
Reddi HV, Wand H, Funke B, Zimmermann MT, Lebo MS, Qian E, Shirts BH, Zou YS, Zhang BM, Rose NC, Abu-El-Haija A, ACMG Laboratory Quality Assurance Committee. Electronic address: documents@acmg.netAuthor
Michael T. Zimmermann PhD Director, Assistant Professor in the Clinical and Translational Science Institute department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Genetic TestingGenetics, Medical
Genomics
Humans
Laboratories
United States